NCT00027898View on ClinicalTrials.gov

Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

January 31, 2006

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bortezomib

Given IV

DRUG

carboplatin

Given IV

DRUG

etoposide

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

80217-3364

University of Colorado, Denver

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00027898 - Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter